سعر سيرفاريكس 0.5 مل لقاح 2024

Cervarix 0.5 ml suspension for injection (HPV-16 and HPV-18 L1 proteins, adjuvanted, adsorbed). GSK. Prevention of HPV-related anogenital premalignant lesions and cervical/anal cancers per EU SmPC; Egyptian leaflet not opened.

• From age 9 years: prevention of premalignant anogenital lesions (cervical, vulvar, vaginal, anal) and cervical and anal cancers causally related to certain oncogenic HPV types (EMA Cervarix).Population: Males and females from 9 years (per EU labelling)European Medicines Agency (EMA)

• Very common: headache, myalgia, injection-site reactions (pain, redness, swelling), fatigue (EMA Cervarix overview).International label, same product · European Medicines Agency (EMA)